CircSCN8A suppresses malignant progression and induces ferroptosis in non-small cell lung cancer by regulating miR-1290/ACSL4 axis

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: gLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. DOI:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Bade BC, Dela Cruz CS. Lung Cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41(1):1–24.
   PubMed Web of Science ®Google Scholar
• Relli V, Trerotola M, Guerra E, et al. Abandoning the notion of non-small cell lung cancer. Trends Mol Med. 2019;25(7):585–594. DOI:10.1016/j.molmed.2019.04.012
   PubMed Web of Science ®Google Scholar
• Kocher F, Hilbe W, Seeber A, et al. Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry. Lung Cancer. 2015;87:193–200.
   PubMed Web of Science ®Google Scholar
• Duma N, Santana-Davila R, Molina JR. Non–small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc. 2019;94(8):1623–1640.
   PubMed Web of Science ®Google Scholar
• Arbour KC, Riely GJ. Systemic therapy for locally advanced and metastatic non–small cell lung cancer: a review. JAMA. 2019;322(8):764–774.
   PubMed Web of Science ®Google Scholar
• Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39–51. DOI:10.1016/j.jtho.2015.09.009
   PubMed Web of Science ®Google Scholar
• Ebbesen KK, Hansen TB, Kjems J. Insights into circular RNA biology. RNA Biol. 2017;14(8):1035–1045.
   PubMed Web of Science ®Google Scholar
• Chen LL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020;21(8):475–490.
   PubMed Web of Science ®Google Scholar
• Zhou WY, Cai ZR, Liu J, et al. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19(1):172. DOI:10.1186/s12943-020-01286-3
   PubMed Web of Science ®Google Scholar
• Verduci L, Tarcitano E, Strano S, et al. CircRnas: role in human diseases and potential use as biomarkers. Cell Death Dis. 2021;12(5):468. DOI:10.1038/s41419-021-03743-3
   PubMed Web of Science ®Google Scholar
• Bach DH, Lee SK, Sood AK. Circular RNAs in cancer. Mol Ther Nucleic Acids. 2019;16:118–129.
   PubMedGoogle Scholar
• Kristensen LS, Hansen TB, Venø MT, et al. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565. DOI:10.1038/onc.2017.361
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Jakobsen T, Hager H, et al. The emerging roles of circRnas in cancer and oncology. Nat Rev Clin Oncol. 2022;19(3):188–206. DOI:10.1038/s41571-021-00585-y
   PubMed Web of Science ®Google Scholar
• Chen HH, Zhang TN, Wu QJ, et al. Circular RNAs in lung cancer: recent advances and future perspectives. Front Oncol. 2021;11:664290.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Kang L, Li X, et al. Bioinformatics analysis predicts hsa_circ_0026337/mir-197-3p as a potential oncogenic ceRNA network for non-small cell lung cancers. Anticancer Agents Med Chem. 2022;22(5):874–886. DOI:10.2174/1871520621666210712090721
   PubMed Web of Science ®Google Scholar
• Tang D, Chen X, Kang R, et al. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107–125. DOI:10.1038/s41422-020-00441-1
   PubMed Web of Science ®Google Scholar
• Chen X, Kang R, Kroemer G, et al. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280–296. DOI:10.1038/s41571-020-00462-0
   PubMed Web of Science ®Google Scholar
• Balihodzic A, Prinz F, Dengler MA, et al. Non-coding RNAs and ferroptosis: potential implications for cancer therapy. Cell Death Differ. 2022;29(6):1094–1106. DOI:10.1038/s41418-022-00998-x
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang L, Li H, et al. Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression. Cell Death Dis. 2020;11(7):580. DOI:10.1038/s41419-020-02772-8
   PubMed Web of Science ®Google Scholar
• Verduci L, Strano S, Yarden Y, et al. The circRna–microRNA code: emerging implications for cancer diagnosis and treatment. Mol Oncol. 2019;13(4):669–680. DOI:10.1002/1878-0261.12468
   PubMed Web of Science ®Google Scholar
• Zhong Y, Du Y, Yang X, et al. Circular RNAs function as ceRnas to regulate and control human cancer progression. Mol Cancer. 2018;17(1):79. DOI:10.1186/s12943-018-0827-8
   PubMed Web of Science ®Google Scholar
• Liang ZZ, Guo C, Zou MM, et al. circRNA-miRNA-mRNA regulatory network in human lung cancer: an update. Cancer Cell Int. 2020;20(1):173. DOI:10.1186/s12935-020-01245-4
   PubMed Web of Science ®Google Scholar
• Wang Y, Ren F, Sun D, et al. CircKEAP1 suppresses the progression of lung adenocarcinoma via the miR-141-3p/keap1/nrf2 Axis. Front Oncol. 2021;11:672586.
   PubMed Web of Science ®Google Scholar
• Li C, Zhang J, Yang X, et al. Hsa_circ_0003222 accelerates stemness and progression of non-small cell lung cancer by sponging miR-527. Cell Death Dis. 2021;12(9):807. DOI:10.1038/s41419-021-04095-8
   PubMed Web of Science ®Google Scholar
• Rugamba A, Kang DY, Sp N, et al. Silibinin regulates tumor progression and tumorsphere formation by suppressing PD-L1 expression in non-small cell lung cancer (NSCLC) cells. Cells. 2021;10(7):1632. DOI:10.3390/cells10071632
   PubMed Web of Science ®Google Scholar
• Li B, Zhu L, Lu C, et al. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat Commun. 2021;12(1):295. DOI:10.1038/s41467-020-20527-z
   PubMed Web of Science ®Google Scholar
• Zhao J, Li L, Wang Q, et al. CircRNA expression profile in early-stage lung adenocarcinoma patients. Cell Physiol Biochem. 2017;44(6):2138–2146. DOI:10.1159/000485953
   PubMedGoogle Scholar
• Selamat SA, Chung BS, Girard L, et al. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res. 2012;22(7):1197–1211. DOI:10.1101/gr.132662.111
   PubMed Web of Science ®Google Scholar
• Meister M, Belousov A, Xu EC, et al. Intra-tumor heterogeneity of gene expression profiles in early stage non-small cell lung cancer. J Bioinf Res Stud. 2014;1:1.
   Google Scholar
• Hou J, Aerts J, den Hamer B, et al. Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS ONE. 2010;5(4):e10312. DOI:10.1371/journal.pone.0010312
   PubMed Web of Science ®Google Scholar
• Yan H, Guan Q, He J, et al. Individualized analysis reveals CpG sites with methylation aberrations in almost all lung adenocarcinoma tissues. J Transl Med. 2017;15(1):26. DOI:10.1186/s12967-017-1122-y
   PubMedGoogle Scholar
• Liu T, Zhu J, Du W, et al. AKT2 drives cancer progression and is negatively modulated by miR-124 in human lung adenocarcinoma. Respir Res. 2020;21(1):227. DOI:10.1186/s12931-020-01491-0
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li S, Li F, et al. High-fat diet impairs ferroptosis and promotes cancer invasiveness via downregulating tumor suppressor ACSL4 in lung adenocarcinoma. Biol Direct. 2021;16(1):10. DOI:10.1186/s13062-021-00294-7
   PubMed Web of Science ®Google Scholar
• Kalhori MR, Soleimani M, Arefian E, et al. The potential role of miR-1290 in cancer progression, diagnosis, prognosis, and treatment: an oncomiR or onco-suppressor microRNA? J Cell Biochem. 2022;123(3):506–531. DOI:10.1002/jcb.30191
   PubMed Web of Science ®Google Scholar
• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454.
   PubMed Web of Science ®Google Scholar
• Feng B, Zhou H, Wang T, et al. Insights into circRnas: functional roles in lung cancer management and the potential mechanisms. Front Cell Dev Biol. 2021;9:636913.
   PubMed Web of Science ®Google Scholar
• Igci YZ, Bozgeyik E, Borazan E, et al. Expression profiling of SCN8A and NDUFC2 genes in colorectal carcinoma. Exp Oncol. 2015;37(1):77–80. DOI:10.31768/2312-8852.2015.37(1):77-80
   PubMedGoogle Scholar
• Shi Z, Zhang L, Zheng J, et al. Ferroptosis: biochemistry and Biology in Cancers. Front Oncol. 2021;11:579286–579286. DOI:10.3389/fonc.2021.579286.
   PubMed Web of Science ®Google Scholar
• Xie B, Guo Y. Molecular mechanism of cell ferroptosis and research progress in regulation of ferroptosis by noncoding RNAs in tumor cells. Cell Death Discov. 2021;7(1):101.
   PubMed Web of Science ®Google Scholar
• Yuan H, Li X, Zhang X, et al. Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem Biophys Res Commun. 2016;478(3):1338–1343. DOI:10.1016/j.bbrc.2016.08.124
   PubMed Web of Science ®Google Scholar
• Xiaofei J, Mingqing S, Miao S, et al. Oleanolic acid inhibits cervical cancer Hela cell proliferation through modulation of the ACSL4 ferroptosis signaling pathway. Biochem Biophys Res Commun. 2021;545:81–88.
   PubMed Web of Science ®Google Scholar
• Lu Y, Chan YT, Tan HY, et al. Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/acsl4 axis mediates sorafenib resistance in human hepatocellular carcinoma. J Exp Clin Cancer Res. 2022;41(1):3. DOI:10.1186/s13046-021-02208-x
   PubMed Web of Science ®Google Scholar
• Jarlstad OM, S Kristensen L, Hon CC. Circular RNAs as microRNA sponges: evidence and controversies. Essays Biochem. 2021;65(4):685–696.
   PubMed Web of Science ®Google Scholar
• Guz M, Jeleniewicz W, Cybulski M. An Insight into miR-1290: an Oncogenic miRNA with Diagnostic Potential. Int J Mol Sci. 2022;23(3):1234.
   PubMed Web of Science ®Google Scholar
• Mo D, Gu B, Gong X, et al. miR-1290 is a potential prognostic biomarker in non-small cell lung cancer. J Thorac Dis. 2015;7(9):1570–1579. DOI:10.3978/j.issn.2072-1439.2015.09.38
   PubMed Web of Science ®Google Scholar
• Wu Y, Wei J, Zhang W, et al. Serum exosomal miR-1290 is a potential biomarker for lung adenocarcinoma. Onco Targets Ther. 2020;13:7809–7818.
   PubMed Web of Science ®Google Scholar
• Jin JJ, Liu YH, Si JM, et al. Overexpression of miR-1290 contributes to cell proliferation and invasion of non small cell lung cancer by targeting interferon regulatory factor 2. Int J Biochem Cell Biol. 2018;95:113–120.
   PubMed Web of Science ®Google Scholar
• Zhang WC, Chin TM, Yang H, et al. Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression. Nat Commun. 2016;7(1):11702. DOI:10.1038/ncomms11702
   PubMedGoogle Scholar